Home › Entities › chemical compound › palivizumab

palivizumab

pharmaceutical drug
Class type of: chemical compound Q412765

Facts

8 properties
Instance of
type of chemical entity
Subclass of
chemical compound
Has use
medication[3]
Active ingredient in
Synagis[12]
Has characteristic
biopharmaceutical[4]
Medical condition treated
respiratory syncytial virus infectious disease, lung disease, bronchopulmonary dysplasia, heart disease[5][6][7][8]
Subject has role
antiviral agent, monoclonal antibody[10][11]
World Health Organisation international non-proprietary name
palivizumab[9]
🏷️ Also known as
en Synagis Abbosynagis en anti-RSV en MEDI-493 en palivizumab ar باليفيزوماب ja パリビズマブ uk палівізумаб zh 帕利珠单抗 zh 帕利珠單抗
🔖 Identifiers · 17
OpenAlex ID
C2778644256
ATC code
J06BB16
CAS Registry Number
188039-54-5
ChEMBL ID
CHEMBL1201586
DeCS ID
55978
DrugBank ID
DB00110
Freebase ID
/m/0gdn5s
HSDB ID
8178
MeSH descriptor ID
D000069455
MeSH tree code
D12.776.124.486.485.114.224.060.860, D12.776.124.790.651.114.224.060.860, D12.776.377.715.548.114.224.200.860
MedlinePlus drug identifier
a698034
Microsoft Academic ID (discontinued)
2778644256
Show all 17 identifiers +5
NDF-RT ID
N0000148570
RxNorm CUI
194279
UK Parliament thesaurus ID
428922
UNII
DQ448MW7KS
WikiProjectMed ID
Palivizumab

Report an error or request removal Lineage (PROV-JSON)

🔗 Connections
Medical condition treated 2
heart disease, bronchopulmonary dysplasia
← Drug or therapy used for treatment 2
heart disease, bronchopulmonary dysplasia
Has characteristic 1
biopharmaceutical
Has use 1
medication
Subclass of 1
chemical compound
Subject has role 1
monoclonal antibody
← Product or material produced 1
AstraZeneca (United States)
Press Enter · cited answer in seconds

Summary

palivizumab is a type of chemical entity[1]. palivizumab is a type of chemical compound[2].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . DrugBank. wikidata.org.
  3. [4] ↑ . DrugBank. wikidata.org.
  4. [5] ↑ . Drug Indications Extracted from FAERS. Retrieved . wikidata.org.
  5. [6] ↑ . Drug Indications Extracted from FAERS. Retrieved . wikidata.org.
  6. [7] ↑ . Drug Indications Extracted from FAERS. Retrieved . wikidata.org.
  7. [8] ↑ . Drug Indications Extracted from FAERS. Retrieved . wikidata.org.
  8. [9] ↑ . ChEMBL. Retrieved . wikidata.org.
  9. [10] ↑ . Medical Subject Headings. Retrieved . wikidata.org.
  10. [11] ↑ . DrugBank. Retrieved . wikidata.org.
  11. [12] ↑ . ema.europa.eu. Retrieved . ema.europa.eu. Provenance: wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). palivizumab. Retrieved November 8, 2026, from https://4ort.xyz/entity/palivizumab
MLA “palivizumab.” 4ort.xyz Knowledge Graph, 4ort.xyz, 8 Nov. 2026, https://4ort.xyz/entity/palivizumab.
BibTeX @misc{4ortxyz_palivizumab_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{palivizumab}}, year = {2026}, url = {https://4ort.xyz/entity/palivizumab}, note = {Accessed: 2026-11-08}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): palivizumab — https://4ort.xyz/entity/palivizumab (retrieved 2026-11-08)

Canonical URL: https://4ort.xyz/entity/palivizumab · Last refreshed:

Edit History

Rolling log of changes to this entity's Wikidata record. Values shown reflect the current state of each edited property — follow the history link to see the precise diff for any edit.

  1. 5d ago · Elivan da Silva · 2026-11-04 view diff on Wikidata ↗
    Subject has role → antiviral agent, monoclonal antibody
    Has use → medication
    Medical condition treated → respiratory syncytial virus infectious disease, lung disease, bronchopulmonary dysplasia +1
    Active ingredient in → Synagis
    + 3 other properties edited (see Wikidata diff for full list)
    "Changed [pt] description: medicamento, #temporary_batch_1793813284429"
Live feed via Wikidata EventStreams. New edits appear within minutes of being made on Wikidata.